Loss of smell in patients with aspirin‐exacerbated respiratory disease impacts mental health and quality of life is a research paper published in Clinical & Experimental Allergy (2022). On theSindex it has a DataRank of 0. It has been cited 24 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U19AI095219
National Institutes of Health
Grant: K23AI139352
National Institutes of Health
Grant: R01HL128241
National Institutes of Health
Grant: T32AI007306
National Institutes of Health
Grant: 5T32AI007306-10
IMMUNOLOGIC BASIS OF RESISTANCE AND HYPERSENSITIVITY
National Institutes of Health
Grant: 5U19AI095219-04
Pathophysiologic and therapeutic mechanisms of aspirin exacerbated respiratory d*
National Institutes of Health
Grant: 5K23AI139352-04
The Role of IL-5 and Local Nasal Polyp Immunoglobulin Production in Aspirin-Exacerbated Respiratory Disease
Finnish Medical Society
FWCI
1.88
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals